Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611
This examiner grants 28% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17798531 | OMECAMTIV MECARBIL TABLET | Final Rejection | Amgen Inc. |
| 17503762 | MULTI-PHASE ORAL COMPOSITION FOR DELIVERING ORAL CARE ACTIVE AGENTS | Non-Final OA | The Procter & Gamble Company |
| 17479614 | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Final Rejection | Bayer HealthCare LLC |
| 17840276 | METHODS TO ENHANCE BIOAVAVAILABILITY OF ORGANIC SMALL MOLECULES AND DEPOSITED FILMS MADE THEREFROM | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17268129 | CORE BODY TEMPERATURE REDUCING AGENT, FOOD PRODUCT, AND SLEEP IMPROVING AGENT | Final Rejection | JAPAN TOBACCO INC. |
| 18730194 | DRUG DELIVERY SYSTEM | Non-Final OA | Sever Pharma Solutions |
| 18605521 | METHOD AND DEVICE FOR PROVIDING EFFECTIVE CONTRACEPTION | Final Rejection | Chemo Research, S.L. |
| 18026937 | AGENT FOR IMPROVING SKIN CONDITION | Non-Final OA | Mitsui DM Sugar Co., Ltd. |
| 18709906 | HEIGHT-ADJUSTABLE SPRINKLER | Non-Final OA | BTGIN CO., LTD. |
| 18283379 | COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 17854688 | DISRUPTED CARTILAGE PRODUCTS | Final Rejection | OSIRIS THERAPEUTICS, INC. |
| 18144365 | ANHYDROUS HYDROCOLLOID MATRIX COMPRISING HOMOGENEOUSLY DISTRIBUTED ENCAPSULATED THERAPEUTIC AGENTS | Non-Final OA | Peace Out, LLC |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | Non-Final OA | Kindeva Drug Delivery L.P. |
| 15301281 | CONTRACEPTIVE AND RELATED DEVICE | Non-Final OA | POLY-MED, INC. |
| 18339310 | THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTS | Non-Final OA | The United States of America, as represented by the Secretary of Agriculture |
| 18398021 | SUSPENSION COMPOSITIONS OF MULTI-TARGET INHIBITORS | Final Rejection | AIVIVA BIOPHARMA, INC. |
| 16585630 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | Non-Final OA | Ojai Energetics PBC |
| 17912278 | CANNABINOID MEDICAL CARRIER | Non-Final OA | New York Medical College |
| 18024788 | PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF | Non-Final OA | Herba Invest Europe DOO |
| 18022877 | FRUIT EXTRACTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Non-Final OA | NEUROSCIENCE PHARMA SPA |
| 16968710 | HAEMOSTATIC MATERIAL | Final Rejection | MEDTRADE PRODUCTS LIMITED |
| 18015952 | FORMULATION PRODUCT | Non-Final OA | Nutriigen Ltd. |
| 17809174 | CORONA DISCHARGE TREATED TRANSDERMAL DELIVERY SYSTEM | Final Rejection | Corium, LLC |
| 18057569 | Multi-Nutrient Composition | Final Rejection | Exerkine Corporation |
| 18046551 | Drug Eluting Foams and the Production Thereof | Non-Final OA | Polyganics IP B.V. |
| 17529591 | Drug Eluting Foams and the Production Thereof | Final Rejection | Polyganics IP B.V. |
| 17964270 | TRANSDERMAL DEVICE COMPRISING IBUPROFEN PRODRUG MOLECULES | Non-Final OA | Remedy Diagnostics LLC |
| 17847606 | SAFER AND MORE EFFECTIVE METHODS OF TRANSMUCOSAL DELIVERY FOR RAISING BLOOD PRESSURE | Non-Final OA | Belcher Pharmaceuticals, LLC |
| 17694312 | TOPICAL DRUG DELIVERY DEVICES AND METHODS OF USE | Final Rejection | MJS Solutions, LLC |
| 17401598 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS | Non-Final OA | Pike Therapeutics Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy